Source: Pharmaceutical Benefits Scheme (AU) Revision Year: 2020 Publisher: Alphapharm Pty Ltd, Level 1, 30 The Bond, 30 – 34 Hickson Road, Millers Point NSW 2000, www.mylan.com.au
Treatment of patients with symptomatic benign prostatic hyperplasia (BPH) with an enlarged prostate.
The recommended dosage is one 5 mg tablet daily with or without food.
Adjustments in dosage are not necessary in patients with varying degrees of renal insufficiency (creatinine clearances as low as 9 mL/minute) as pharmacokinetic studies did not indicate any change in the disposition of finasteride.
No adjustment in dosage is required although pharmacokinetic studies indicated that the elimination of finasteride is somewhat decreased in patients aged over 70 years.
Patients have received single doses of finasteride up to 400 mg and multiple doses of finasteride up to 80 mg/day for three months without adverse effects.
No specific treatment of overdosage with finasteride is recommended. General supportive care should be given.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).
In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.
Store below 30°C. Protect from light.
Crushed or broken tablets of finasteride should not be handled by women when they are or may potentially be pregnant (see Section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE, Section 4.6 FERTILITY, PREGNANCY AND LACTATION, EXPOSURE TO FINASTERIDE, RISK TO A MALE FOETUS).
Available in blister packs containing 28 tablets (Al/Al) and 30 tablets (PVC/PE/PVDC/Al).
Some strengths, pack sizes and/or pack types may not be marketed.
In Australia, any unused medicine or waste material should be disposed of by taking it to your local pharmacy.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
